Review papers with raw data transparency

Quick appraisal

The preprint reports that chemical collapse of the proton gradient (Delta pH) of the proton motive force (PMF) — triggered by niclosamide and other ionophores — rapidly induces a low‑ATP, non‑replicating, drug tolerant persister state in Mycobacterium tuberculosis, with tolerance strength tuned by extracellular pH and linked to a reproducible transcriptional program and three CRISPRi‑validated genes (Rv0057, Rv2428/ahpC, Rv3289c) PMF pH gradient drives drug tolerance (preprint)

Detailed critique and synthesis

Why these results matter biologically

The paper connects a core bioenergetic parameter — the proton gradient across the mycobacterial envelope — to rapid induction of a drug tolerant, low‑ATP state. That makes mechanistic sense: PMF powers ATP synthesis, transport, and many metabolic processes; selective collapse of Delta pH with retained or only partially lost Delta Psi plausibly allows survival while disabling drug killing mechanisms that rely on energy or toxin uptake. This is concordant with literature linking low energy states to persister formation in bacteria Review on persisters mechanisms

Strengths

• Comprehensive chemical screen (2,336 FDA drugs) using rigorous viability/readouts and orthogonal assays (MIC, time kills, intracellular assays) increases confidence that the NCA effect is real and not an artefact Large FDA drug screen
• Use of multiple PMF perturbants (NCA, CCCP, nigericin, valinomycin) and orthogonal dyes (DiOC2(3) for Delta Psi, BCECF-AM for intracellular pH) provides mechanistic dissection of PMF components PMF component assays
• Transcriptomics plus targeted CRISPRi knockdowns provide a causal link from Delta pH to specific gene functions that modify tolerance and bioenergetics (ATP/pH) — not only correlative signatures RNAseq plus CRISPRi causal evidence

Limitations, caveats, and blindspots

1. In vitro versus in vivo relevance: The central experiments are high‑inoculum in vitro cultures and THP‑1 macrophages; granuloma microenvironments are heterogeneous and complex. The preprint acknowledges limited in vivo validation and the need for pharmacokinetic/lesional concentration data to assess whether niclosamide reaches Delta pH‑disrupting concentrations in lesions Authors acknowledge in vivo limitations
2. Niclosamide pleiotropy and off-targets: Niclosamide is a promiscuous bioactive compound with known host effects (mitochondrial uncoupling, autophagy modulation) and poor systemic exposure when given orally; off‑target host modulation could confound intracellular assays and translation NCA known pleiotropy noted
3. CRISPRi knockdown depth: CRISPRi yields hypomorphic reductions; residual gene expression could mask full loss‑of‑function phenotypes. The claim that Rv0057 promotes tolerance (knockdown enhanced survival) seems counterintuitive and deserves more exploration including knockouts or complementation to rule out polar or indirect effects CRISPRi used to implicate genes
4. Specificity of Delta pH effect across strains/species: The study tests additional Mtb strains and two other bacterial species with some effects reported, but more strains (clinical isolates, MDR/XDR isolates) and primary macrophages or animal models would strengthen generality claims Strain breadth noted
5. PZA interplay complexity: The paper reports Delta pH disruption enhances susceptibility to pyrazinamide (PZA) — potentially consistent with PZA requiring acidic intrabacterial conditions — but PZA mode of action remains debated and environment/drug metabolism interactions are complex; citing live‑cell pH imaging studies and the newer PZA mechanistic preprint helps situate this result PZA mechanism contested (2015)New PZA pH model (2025 preprint)

Reproducibility and data access

• Authors deposited RNAseq SRA accession PRJNA1226648 and provided an analysis GitHub repository: https://github.com/HassanEldesouky13/PMF-inhibitors-TB-analysis — good openness practice though the SRA entry currently shows no metadata in the scraped summary; users should validate raw file accessibility and sample metadata before reanalysis SRA and GitHub data availability
• Methods appear sufficiently described (dyes, RNAseq pipeline Bowtie2, NextSeq, CRISPRi induction conditions) to permit replication, but critical materials like exact strain stocks, sequence of sgRNAs, and NCA formulations/concentrations used for intracellular assays should be confirmed in supplementary materials or deposited sequences for full reproducibility.

How convincing is the central causal claim?

Moderately to strongly convincing for an in vitro chemically induced persister model: the authors use orthogonal PMF probes, multiple PMF perturbants, dose/pH titrations, transcriptomics, and genetic perturbation to triangulate that Delta pH collapse causes a reproducible drug tolerant state. Key caveats remain about translation to in vivo lesions and niclosamide pharmacology. The confidence is bolstered by independent literature showing pH microenvironments drive bacterial adaptation and persistence (e.g., FLIM pH imaging studies in bacteria showing pH gradients are biologically meaningful) FLIM pH imaging supports pH gradients in bacteria

Practical implications and translational cautions

• As the authors note, using NCA to treat TB would be unwise without full understanding: NCA can increase tolerance to frontline drugs in vitro and has poor systemic exposure; repurposing must account for lesion PK, host effects and the biphasic pH relationship Warning on repurposing NCA
• Conversely, the study suggests that manipulating intrabacterial pH or targeting the transcriptional/metabolic responses to Delta pH may be an anti‑persistence strategy. In particular, genes/pathways identified (oxidative stress defenses, isocitrate lyase/glyoxylate shunt, redox balance) are plausible drug targets to combine with standard antibiotics to prevent persistence.

Concrete experimental next steps to strengthen claims

1. In vivo validation: test whether NCA or controlled Delta pH perturbation promotes tolerance or affects relapse in murine TB models using lesion PK/PD and different routes of administration; measure lesion pH and intrabacterial pH (live imaging where possible) during treatment Authors recommend in vivo studies
2. Genetic validation: construct clean deletion mutants and complemented strains for Rv0057, Rv2428, and Rv3289c to confirm CRISPRi results and examine epistasis with known persistence regulators (e.g., toxin-antitoxin systems, energy metabolism genes).
3. Mechanistic biochemistry: measure specific proton flux, membrane permeability to weak acids, and ATP synthase activity after Delta pH collapse to map which processes are required for the tolerant state; compare to PZA responses given the PZA/Delta pH link discussed above New PZA pH model (preprint)

Summary judgement

Overall the study delivers a strong, well‑supported in vitro argument that collapse of Delta pH can rapidly produce a persister‑like, drug tolerant state in Mtb; the experiments are multi-pronged (chemical biology, PMF probes, transcriptomics, CRISPRi) and data are available for reanalysis, but translation into clinical significance requires lesion PK/PD, in vivo models and careful consideration of niclosamide pleiotropy.

Run AI Biology Analysis

Author Review Buttons